Guided Therapeutics, Inc. (GTHP)
OTCMKTS
· Delayed Price · Currency is USD
0.2300
0.00 (0.00%)
Jun 18, 2025, 3:49 PM EDT
Guided Therapeutics Market Cap
Guided Therapeutics has a market cap or net worth of $18.16 million as of June 18, 2025. Its market cap has increased by 129.40% in one year.
Market Cap
18.16M
Enterprise Value
22.26M
Revenue
1,000.00
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since July 1, 1997, Guided Therapeutics's market cap has decreased from 448.72M to 18.16M, a decrease of -95.95%. That is a compound annual growth rate of -10.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Elite Pharmaceuticals | 790.52M |
| Veradigm | 764.23M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 437.04M |
| Northwest Biotherapeutics | 403.91M |
| American Oncology Network | 384.27M |